Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apolizumab (Hu1D10) in relapsed or refractory B-cell non-Hodgkin's lymphoma
NCT00014664Phase 2Unknown
- Sponsor
- PDL BioPharma
- Start
- Oct 2000
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of apolizumab in B-cell non-Hodgkin lymphoma (B-NHL), sponsored by PDL BioPharma. Status: unknown.
02
Drugs
apolizumab
03
Conditions
B-cell non-Hodgkin lymphoma (B-NHL)
Beyond the preview
Go deeper on NCT00014664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014664.